{"id":"https://openalex.org/W3095200845","doi":"https://doi.org/10.1182/blood-2020-134269","title":"FT-4202, an Allosteric Activator of Pyruvate Kinase-R, Demonstrates Proof of Mechanism and Proof of Concept after a Single Dose and after Multiple Daily Doses in a Phase 1 Study of Patients with Sickle Cell Disease","display_name":"FT-4202, an Allosteric Activator of Pyruvate Kinase-R, Demonstrates Proof of Mechanism and Proof of Concept after a Single Dose and after Multiple Daily Doses in a Phase 1 Study of Patients with Sickle Cell Disease","publication_year":2020,"publication_date":"2020-11-05","ids":{"openalex":"https://openalex.org/W3095200845","doi":"https://doi.org/10.1182/blood-2020-134269","mag":"3095200845"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-134269","doi":"https://doi.org/10.1182/blood-2020-134269","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-134269","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051820244","display_name":"Clark Brown","orcid":"https://orcid.org/0000-0003-0674-0213","observed_orcids":["https://orcid.org/0000-0003-0674-0213"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210146983","display_name":"Children's Healthcare of Atlanta","ror":"https://ror.org/050fhx250","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146983"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Clark Brown","raw_affiliation_strings":["Department of Pediatrics, Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and the Department of Pediatrics, Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and the Department of Pediatrics, Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016886758","display_name":"Kimberly Cruz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090951","display_name":"Advanced Pharma","ror":"https://ror.org/00c3pmw05","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210090951"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly Cruz","raw_affiliation_strings":["Advanced Pharma, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Pharma, Miami, FL","institution_ids":["https://openalex.org/I4210090951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022133503","display_name":"Theodosia A. Kalfa","orcid":"https://orcid.org/0000-0002-0426-9686","observed_orcids":["https://orcid.org/0000-0002-0426-9686"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theodosia A. Kalfa","raw_affiliation_strings":["Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047162260","display_name":"Frans A. Kuypers","orcid":"https://orcid.org/0000-0003-0731-1007","observed_orcids":["https://orcid.org/0000-0003-0731-1007"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frans A. Kuypers","raw_affiliation_strings":["Children's Hospital Oakland Research Institute, Oakland, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital Oakland Research Institute, Oakland, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030174386","display_name":"Santosh L. Saraf","orcid":"https://orcid.org/0000-0002-8584-4194","observed_orcids":["https://orcid.org/0000-0002-8584-4194"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Santosh L. Saraf","raw_affiliation_strings":["Department of Medicine, University of Illinois at Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Illinois at Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017765783","display_name":"Jeremie Heath Estepp","orcid":"https://orcid.org/0000-0002-2257-0421","observed_orcids":["https://orcid.org/0000-0002-2257-0421"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremie H. Estepp","raw_affiliation_strings":["Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009105992","display_name":"Luke R. Smart","orcid":"https://orcid.org/0000-0003-4083-0060","observed_orcids":["https://orcid.org/0000-0003-4083-0060"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luke R. Smart","raw_affiliation_strings":["Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067822812","display_name":"Punam Malik","orcid":"https://orcid.org/0000-0002-8942-2108","observed_orcids":["https://orcid.org/0000-0002-8942-2108"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Punam Malik","raw_affiliation_strings":["Cincinnati Children's Hospital Medical Center, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cincinnati Children's Hospital Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark Lerman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121444","display_name":"Atlanta Center for Medical Research","ror":"https://ror.org/02gx57r28","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210121444"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Lerman","raw_affiliation_strings":["Atlanta Center for Medical Research, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlanta Center for Medical Research, Atlanta, GA","institution_ids":["https://openalex.org/I4210121444"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009530556","display_name":"Renae Mayer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renae Mayer","raw_affiliation_strings":["Lynn Institute, Tulsa, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lynn Institute, Tulsa, OK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081293261","display_name":"Maria D. Ribadeneira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113508","display_name":"Forma Therapeutics (United States)","ror":"https://ror.org/0263fkh30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210113508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria D. Ribadeneira","raw_affiliation_strings":["Forma Therapeutics, Inc., Watertown, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forma Therapeutics, Inc., Watertown, MA","institution_ids":["https://openalex.org/I4210113508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042954440","display_name":"Sanjeev Forsyth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113508","display_name":"Forma Therapeutics (United States)","ror":"https://ror.org/0263fkh30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210113508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanjeev Forsyth","raw_affiliation_strings":["Forma Therapeutics, Inc., Watertown, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forma Therapeutics, Inc., Watertown, MA","institution_ids":["https://openalex.org/I4210113508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059472140","display_name":"Patricia E. Schroeder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113508","display_name":"Forma Therapeutics (United States)","ror":"https://ror.org/0263fkh30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210113508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia Schroeder","raw_affiliation_strings":["Forma Therapeutics, Inc., Watertown, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forma Therapeutics, Inc., Watertown, MA","institution_ids":["https://openalex.org/I4210113508"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eric Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113508","display_name":"Forma Therapeutics (United States)","ror":"https://ror.org/0263fkh30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210113508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Wu","raw_affiliation_strings":["Forma Therapeutics, Inc., Watertown, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forma Therapeutics, Inc., Watertown, MA","institution_ids":["https://openalex.org/I4210113508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066471470","display_name":"Patrick Francis Kelly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113508","display_name":"Forma Therapeutics (United States)","ror":"https://ror.org/0263fkh30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210113508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Kelly","raw_affiliation_strings":["Forma Therapeutics, Inc., Watertown, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forma Therapeutics, Inc., Watertown, MA","institution_ids":["https://openalex.org/I4210113508"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061155508","display_name":"Marilyn J. Telen","orcid":"https://orcid.org/0000-0003-3809-1780","observed_orcids":["https://orcid.org/0000-0003-3809-1780"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marilyn J. Telen","raw_affiliation_strings":["Department of Medicine, Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Duke University, Durham, NC","institution_ids":["https://openalex.org/I170897317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":2.4157,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.89281102,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"19","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12286","display_name":"Erythrocyte Function and Pathophysiology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12094","display_name":"Hemoglobin structure and function","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allosteric-activators","display_name":"allosteric activators","score":0.9229999780654907},{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":1.0},{"id":"https://openalex.org/keywords/2-3-bisphosphoglycerate","display_name":"2,3-diphosphoglycerate","score":0.9110000133514404},{"id":"https://openalex.org/keywords/erythrocyte-atp","display_name":"erythrocyte ATP","score":0.949999988079071},{"id":"https://openalex.org/keywords/oxygen-affinity","display_name":"oxygen affinity","score":0.8830000162124634},{"id":"https://openalex.org/keywords/erythrocyte-deformability","display_name":"erythrocyte deformability","score":0.8169999718666077},{"id":"https://openalex.org/keywords/osmolality","display_name":"osmolality","score":0.6320000290870667},{"id":"https://openalex.org/keywords/hemolysis","display_name":"hemolysis","score":0.4749999940395355},{"id":"https://openalex.org/keywords/vessel-occlusion","display_name":"vascular occlusion","score":0.7630000114440918},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.7068175077438354},{"id":"https://openalex.org/C2779902561","wikidata":"https://www.wikidata.org/wiki/Q471706","display_name":"Hemolysis","level":2,"score":0.5550028085708618},{"id":"https://openalex.org/C2779676291","wikidata":"https://www.wikidata.org/wiki/Q25325349","display_name":"Cardioprotection","level":3,"score":0.5467114448547363},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5086789727210999},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47740593552589417},{"id":"https://openalex.org/C2988731192","wikidata":"https://www.wikidata.org/wiki/Q7410159","display_name":"Blood sampling","level":2,"score":0.45740464329719543},{"id":"https://openalex.org/C2780854706","wikidata":"https://www.wikidata.org/wiki/Q900970","display_name":"Pyruvate kinase","level":4,"score":0.4566549062728882},{"id":"https://openalex.org/C2779778602","wikidata":"https://www.wikidata.org/wiki/Q5260068","display_name":"Deoxygenation","level":3,"score":0.4112621247768402},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3575206696987152},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3093045949935913},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3009423613548279},{"id":"https://openalex.org/C20251656","wikidata":"https://www.wikidata.org/wiki/Q162643","display_name":"Glycolysis","level":3,"score":0.2669324278831482},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.20029816031455994},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.16444268822669983},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.0962943434715271},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-134269","doi":"https://doi.org/10.1182/blood-2020-134269","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-134269","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2994872638","https://openalex.org/W3095689290","https://openalex.org/W4404412959","https://openalex.org/W3096234308","https://openalex.org/W3157601060","https://openalex.org/W4389489310","https://openalex.org/W3214160259","https://openalex.org/W3212462064","https://openalex.org/W3213131678","https://openalex.org/W4389246695"],"abstract_inverted_index":{"I":[0],"NTRODUCTION:":[1],"The":[2],"hallmark":[3],"of":[4,35,63,236,318,330,345,375,400,425,443,462,467,487,508,515,587,592,619,639,654,659,677,711,747,766,853,867,881],"sickle":[5],"cell":[6,20,28],"disease":[7],"(SCD)":[8],"is":[9,130,244,256],"hemoglobin":[10],"S":[11],"(HbS)":[12],"polymerization":[13],"upon":[14],"deoxygenation,":[15],"resulting":[16,71,601],"in":[17,72,80,126,133,139,147,316,328,343,385,482,540,574,602,631,637,662,682],"red":[18],"blood":[19,187],"(RBC)":[21],"sickling,":[22],"oxidative":[23],"damage,":[24,26],"membrane":[25,392,556,614],"hemolysis,":[27],"adhesion,":[29],"and":[30,52,76,101,114,122,145,152,159,183,199,215,219,246,263,336,357,378,506,553,598,611,634,674,786],"vaso-occlusion.":[31],"Exacerbating":[32],"the":[33,37,120,157,196,201,238,247,261,267,291,401,465,468,541,651,671],"pathogenesis":[34],"SCD,":[36,137,643],"HbS":[38,380,390],"RBC":[39,55,210,351,358,381,391,549,555,609,613,647],"has":[40,569],"[1]":[41],"increased":[42,354,498,545,599,603],"(\u2191)":[43],"2,3-DPG":[44,74,100,359,597],"with":[45,104,136,164,212,371,397,415,430,453,493,544,576,622,642,645,684],"decreased":[46,361,373,596,606],"(\u2193)":[47],"O2":[48,109,368,604],"affinity":[49,369],"(\u2191":[50],"P50)":[51],"[2]":[53],"\u2193":[54,73,111],"ATP.":[56],"FT-4202,":[57],"a":[58,140,372,398,422,570,579],"small":[59],"molecule":[60],"allosteric":[61],"activator":[62],"erythrocyte":[64],"pyruvate":[65],"kinase":[66],"(PKR),":[67],"increases":[68],"PKR":[69,655],"activity":[70,676],"levels":[75,79,526],"\u2191":[77,102,108,115],"ATP":[78,352],"RBCs.":[81],"In":[82,156,290,427,485],"healthy":[83],"volunteer":[84],"(HV)":[85],"studies":[86,539],"(Kalfa":[87],"et":[88],"al.":[89],"Blood":[90,704,740,759,773,779,794],"2019),":[91],"FT-4202":[92,129,170,305,335,446,568,593,678],"was":[93,189,394,450],"well":[94,451],"tolerated,":[95,452],"demonstrating":[96],"physiologic":[97],"responses":[98],"(\u2193":[99,551],"ATP)":[103],"biologic":[105],"effects":[106],"including":[107,322,409],"affinity,":[110,605],"reticulocytes":[112,504],"(P<.001)":[113],"Hb":[116,412,497,546],"(ns).":[117],"Based":[118],"on":[119,559,707,743,762,849,863,877],"safety":[121,271,572],"pharmacokinetic/pharmacodynamic":[123],"(PK/PD)":[124],"profile":[125,573],"HV":[127],"studies,":[128,649],"being":[131],"evaluated":[132],"patients":[134],"(pts)":[135],"first":[138],"single":[141,423,580,590],"dose":[142,198,424,581,591],"(SD)":[143],"cohort":[144,243,250],"then":[146],"multiple-dose":[148],"(MD)":[149],"cohorts":[150,665],"(14-day":[151],"12-week)":[153],"[NCT03815695].":[154],"METHODS:":[155],"SD":[158,239,262,292],"14-day":[160,469],"MD":[161,249],"cohorts,":[162],"pts":[163,295,333,348,429,491,543,575,641,683],"SCD":[165,431,489,577],"were":[166,230,288,383,417,510],"randomized":[167],"3:1":[168],"to":[169,193,285,475,518,524,528,563,584,595,668],"or":[171,282,307,447,582,713,749,768,855,869,883],"placebo.":[172,350],"Safety":[173],"assessments":[174],"included":[175,206],"treatment-emergent":[176],"adverse":[177,279],"events":[178,280],"(TEAEs),":[179],"vital":[180],"signs,":[181],"ECGs":[182],"laboratory":[184],"parameters.":[185],"PK/PD":[186],"sampling":[188],"performed":[190],"for":[191,477],"up":[192,583],"72h":[194],"after":[195,365,421,512],"last":[197],"at":[200,464],"end-of-study":[202],"visit;":[203],"PD":[204],"parameters":[205,522,636],"2,3-DPG,":[207],"ATP,":[208,600],"P50,":[209],"deformability":[211,382,550],"controlled":[213],"deoxygenation":[214],"reoxygenation":[216],"(Lorrca\u00ae":[217,222],"oxygenscan)":[218],"varying":[220],"osmolality":[221],"osmoscan).":[223],"To":[224],"maintain":[225],"study":[226,560],"blind,":[227],"pt":[228,270,286,455,479],"identifiers":[229],"removed":[231],"when":[232],"needed.":[233],"RESULTS:":[234],"As":[235],"17-July-2020,":[237],"(700":[240],"mg":[241,253,304,445,624],"FT-4202)":[242],"complete":[245],"1st":[248],"(MD-1,":[251],"300":[252,444,623],"once":[254],"daily)":[255],"enrolling.":[257],"Unblinded":[258],"data":[259,265,687],"from":[260,266],"blinded":[264,617],"MD-1,":[268,440],"3":[269,323,337,428,488,640],"lead-in":[272],"(randomized":[273],"2:1)":[274],"are":[275,480,666],"summarized.":[276],"No":[277],"serious":[278],"(SAEs)":[281],"TEAEs":[283,314,324,338,461],"leading":[284],"withdrawal":[287],"reported.":[289],"cohort,":[293],"7":[294,319,529],"(2":[296],"males,":[297],"5":[298,331],"females,":[299,433],"all":[300,386,434],"HbSS)":[301,435],"received":[302],"700":[303],"(n=5)":[306],"placebo":[308,448],"(n=2).":[309],"Six":[310],"transient":[311],"Grade":[312,459],"1":[313,454,501],"occurred":[315],"4":[317,527],"(57%)":[320],"pts,":[321],"(arthralgia,":[325],"headache,":[326],"palpitations)":[327],"2":[329,344,346,460,486,542,638],"(40%)":[332],"receiving":[334,349,578],"(back":[339],"pain,":[340],"myalgia,":[341],"pruritis)":[342],"(100%)":[347],"concentrations":[353,360],"by":[355,362,499],"30%":[356],"26%":[363],"24h":[364,420],"FT-4202.":[366,426],"Increased":[367],"(\u2193P50)":[370],"point":[374],"sickling":[376],"(PoS)":[377],"improved":[379,511,548,554,608,612,646],"observed":[384,419],"FT-4202-treated":[387],"pts.":[388],"Improved":[389,406],"function":[393,557],"also":[395,418],"demonstrated":[396],"shift":[399],"osmoscan":[402],"results":[403,618],"towards":[404],"normal.":[405],"hematologic":[407,633],"parameters,":[408],"~0.9":[410],"g/dL":[411],"increase":[413],"compared":[414],"placebo,":[416],"(3":[432],"who":[436],"thus":[437],"far":[438],"completed":[439],"14":[441,513,585,627],"days":[442,514,530,586,628],"daily":[449,620,680],"reporting":[456],"transient,":[457],"unrelated":[458],"nausea/vomiting":[463],"end":[466],"dosing":[470,621],"period.":[471],"Laboratory":[472],"changes":[473],"relative":[474,562],"pretreatment":[476],"each":[478],"shown":[481],"Table":[483],"1.":[484],"MD-1":[490],"treated":[492],"FT-4202/placebo":[494,625],"(currently":[495],"blinded),":[496],">":[500],"g/dL,":[502],"%":[503],"decreased,":[505],"markers":[507],"hemolysis":[509],"treatment":[516,561],"(compared":[517],"pre-treatment":[519,525,564],"levels).":[520],"Hematologic":[521],"returned":[523],"post-treatment":[531],"(data":[532],"not":[533],"shown)":[534],"without":[535],"clinical":[536,660],"AEs.":[537],"Functional":[538],"showed":[547],"PoS)":[552],"while":[558],"and/or":[565],"post-treatment.":[566],"CONCLUSION:":[567],"favorable":[571],"dosing.":[588],"A":[589],"led":[594],"PoS,":[607],"deformability,":[610],"function.":[615],"Initial":[616],"over":[626],"show":[629],"improvement":[630],"both":[632],"hemolytic":[635],"along":[644],"functional":[648],"suggesting":[650],"pharmacodynamic":[652],"consequences":[653],"activation":[656],"may":[657],"be":[658,689],"benefit":[661],"SCD.":[663],"Multiple-dose":[664],"ongoing":[667],"further":[669],"evaluate":[670],"safety,":[672],"PK/PD,":[673],"biological":[675],"following":[679],"administration":[681],"SCD;":[685],"updated":[686],"will":[688],"presented.":[690],"Disclosures":[691],"Brown:":[692],"Imara,":[693],"Inc.:":[694,719,736,812,816,821,826,831,836,844],"Consultancy,":[695,720,726,847,875],"Research":[696,701,716,721,727,732,737,776,788,799,841,858,872],"Funding;":[697,702,717,728,789,842,859,873],"Forma":[698,729,781,810],"Therapeutics,":[699,730,735,774,780,782,811,815,820,825,830,835],"Inc,:":[700],"Global":[703,758,772,793],"Therapeutics:":[705,741,760,795,840],"Membership":[706,742,761,848,862,876],"an":[708,744,763,850,864,878],"entity's":[709,745,764,851,865,879],"Board":[710,746,765,852,866,880],"Directors":[712,748,767,854,868,882],"advisory":[714,750,769,856,870,884],"committees,":[715,751,857,871],"Novartis,":[718,757],"Funding.":[722,733,738,777,800],"Kalfa:Agios":[723],"Pharmaceuticals,":[724],"Inc:":[725,731],"Kuypers:Forma":[734],"Saraf:Global":[739],"Other:":[752],"Advisory":[753],"Boards,":[754],"Speakers":[755],"Bureau;":[756],"committees;":[770],"Pfizer,":[771,783],"Novartis:":[775,874],"Estepp:Global":[778],"Eli":[784],"Lilly":[785],"Co:":[787],"Daiichi":[790],"Sankyo,":[791],"Esperion,":[792],"Consultancy;":[796,845],"ASH,":[797],"NHLBI:":[798],"Malik:Aruvant":[801],"Sciences,":[802,809],"CSL":[803,860],"Behring:":[804,861],"Patents":[805],"&":[806],"Royalties;":[807],"Aruvant":[808],"Consultancy.":[813],"Ribadeneira:Forma":[814],"Current":[817,822,827,832,837],"Employment.":[818,823,828,833,838],"Forsyth:Forma":[819],"Schroeder:Forma":[824],"Wu:Forma":[829],"Kelly:Forma":[834],"Telen:Forma":[839],"GlycoMimetics":[843],"Pfizer:":[846],"committees.":[885]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-11-09T00:00:00"}